Ranking of non-coding pathogenic variants and putative essential regions of the human genome.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
20 11 2019
Historique:
received: 30 05 2019
accepted: 28 10 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 3 3 2020
Statut: epublish

Résumé

A gene is considered essential if loss of function results in loss of viability, fitness or in disease. This concept is well established for coding genes; however, non-coding regions are thought less likely to be determinants of critical functions. Here we train a machine learning model using functional, mutational and structural features, including new genome essentiality metrics, 3D genome organization and enhancer reporter data to identify deleterious variants in non-coding regions. We assess the model for functional correlates by using data from tiling-deletion-based and CRISPR interference screens of activity of cis-regulatory elements in over 3 Mb of genome sequence. Finally, we explore two user cases that involve indels and the disruption of enhancers associated with a developmental disease. We rank variants in the non-coding genome according to their predicted deleteriousness. The model prioritizes non-coding regions associated with regulation of important genes and with cell viability, an in vitro surrogate of essentiality.

Identifiants

pubmed: 31748530
doi: 10.1038/s41467-019-13212-3
pii: 10.1038/s41467-019-13212-3
pmc: PMC6868241
doi:

Substances chimiques

Chromatin 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5241

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH113715
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002550
Pays : United States

Références

Science. 2018 Apr 20;360(6386):327-331
pubmed: 29674594
Am J Hum Genet. 2016 Sep 1;99(3):595-606
pubmed: 27569544
Nature. 2014 Mar 27;507(7493):455-461
pubmed: 24670763
Genet Med. 2018 Apr;20(4):464-469
pubmed: 28914269
Curr Biol. 2008 Jun 24;18(12):883-9
pubmed: 18571414
PLoS One. 2017 Aug 10;12(8):e0181604
pubmed: 28797091
Am J Hum Genet. 2015 Aug 6;97(2):199-215
pubmed: 26166479
Genome Biol. 2019 Feb 11;20(1):32
pubmed: 30744685
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6131-8
pubmed: 24753594
Genome Biol. 2014;15(10):480
pubmed: 25273974
Bioinformatics. 2015 May 15;31(10):1536-43
pubmed: 25583119
PLoS Genet. 2010 Oct 14;6(10):e1001154
pubmed: 20976243
Nat Genet. 2016 Feb;48(2):214-20
pubmed: 26727659
Nature. 2018 Feb 8;554(7691):239-243
pubmed: 29420474
Bioinformatics. 2008 Aug 15;24(16):1787-92
pubmed: 18562267
Science. 2016 Nov 11;354(6313):769-773
pubmed: 27708057
Am J Hum Genet. 2011 Jan 7;88(1):70-5
pubmed: 21167467
Bioinformatics. 2012 Jul 15;28(14):1919-20
pubmed: 22576172
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
PLoS Comput Biol. 2010 Dec 02;6(12):e1001025
pubmed: 21152010
N Engl J Med. 2015 Jun 4;372(23):2235-42
pubmed: 26014595
Nat Rev Genet. 2018 Jan;19(1):51-62
pubmed: 29082913
Nat Genet. 2015 Jun;47(6):598-606
pubmed: 25938943
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nat Commun. 2018 Dec 19;9(1):5380
pubmed: 30568279
Clin Genet. 2016 Jun;89(6):700-7
pubmed: 26757139
Mol Cell. 2019 Nov 7;76(3):453-472.e8
pubmed: 31519520
Nature. 2013 Nov 14;503(7475):290-4
pubmed: 24141950
Nature. 2015 Feb 19;518(7539):317-30
pubmed: 25693563
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Nature. 2018 Mar 29;555(7698):611-616
pubmed: 29562236
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D514-7
pubmed: 15608251
Nucleic Acids Res. 2007 Jan;35(Database issue):D88-92
pubmed: 17130149
JAMA. 2014 Nov 12;312(18):1880-7
pubmed: 25326637
Nat Methods. 2017 Jun;14(6):629-635
pubmed: 28417999
Nat Methods. 2018 Feb;15(2):141-149
pubmed: 29256496
Hum Genet. 2017 Jun;136(6):665-677
pubmed: 28349240
Cell Rep. 2016 Nov 15;17(8):2042-2059
pubmed: 27851967
Nat Methods. 2015 Oct;12(10):931-4
pubmed: 26301843
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nat Genet. 2018 Mar;50(3):333-337
pubmed: 29483654
Nat Genet. 2017 Oct;49(10):1539-1545
pubmed: 28846100
Genet Med. 2014 Dec;16(12):922-31
pubmed: 24901346
Genet Med. 2013 Jan;15(1):36-44
pubmed: 22995991
PLoS Genet. 2015 Sep 02;11(9):e1005492
pubmed: 26332131
Nature. 2017 Mar 9;543(7644):199-204
pubmed: 28241135
Am J Med Genet A. 2015 Apr;167A(4):902-6
pubmed: 25692887
Hum Mol Genet. 2015 Oct 15;24(R1):R102-10
pubmed: 26152199
Nat Genet. 2017 Apr;49(4):618-624
pubmed: 28288115
Trends Neurosci. 2019 Feb;42(2):115-127
pubmed: 30563709
Science. 2013 Mar 1;339(6123):1074-7
pubmed: 23328393

Auteurs

Alex Wells (A)

Stanford University, Stanford, CA, 94305, USA.

David Heckerman (D)

Department of Computer Sciences, University of California Los Angeles, Los Angeles, CA, 90024, USA.

Ali Torkamani (A)

Scripps Research Translational Institute, La Jolla, CA, 92037, USA.

Li Yin (L)

Scripps Research Translational Institute, La Jolla, CA, 92037, USA.

Jonathan Sebat (J)

Beyster Institute for Psychiatric Genomics, Department of Psychiatry, University of California San Diego, La Jolla, CA, 92093, USA.
Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Department of Pediatrics, University of California San Diego, La Jolla, CA, 92093, USA.

Bing Ren (B)

Ludwig Institute for Cancer Research, La Jolla, CA, 92093, USA.

Amalio Telenti (A)

Scripps Research Translational Institute, La Jolla, CA, 92037, USA. atelenti@scripps.edu.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA. atelenti@scripps.edu.
Vir Biotechnology, Inc., San Francisco, CA, 94158, USA. atelenti@scripps.edu.

Julia di Iulio (J)

Scripps Research Translational Institute, La Jolla, CA, 92037, USA. Julia.diiulio@gmail.com.
Vir Biotechnology, Inc., San Francisco, CA, 94158, USA. Julia.diiulio@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH